SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 134,000
-2,300 (-1.69%)
At close: Dec 5, 2025
30.22% (1Y)
| Market Cap | 10.49T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 32.75 |
| Forward PE | 42.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 266,239 |
| Average Volume | 340,082 |
| Open | 137,900 |
| Previous Close | 136,300 |
| Day's Range | 131,100 - 137,900 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.77 |
| RSI | 61.10 |
| Earnings Date | Feb 4, 2026 |